Novartis looks past psoriasis for even bigger Cosentyx growth frontier

14th November 2017 Uncategorised 0

Novartis’ Cosentyx currently leads a crop of next-gen immunology products from a who’s who of Big Pharma. And the Swiss drugmaker intends to keep it that way.

More: Novartis looks past psoriasis for even bigger Cosentyx growth frontier
Source: fierce